2025-09-01 2026-08-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 10308104 bus:FullAccounts 2025-09-01 2026-08-31 10308104 bus:Micro-entities 2025-09-01 2026-08-31 10308104 bus:AuditExempt-NoAccountantsReport 2025-09-01 2026-08-31 10308104 bus:SmallCompaniesRegimeForAccounts 2025-09-01 2026-08-31 10308104 bus:PrivateLimitedCompanyLtd 2025-09-01 2026-08-31 10308104 2025-09-01 2026-08-31 10308104 2026-08-31 10308104 bus:RegisteredOffice 2025-09-01 2026-08-31 10308104 core:WithinOneYear 2026-08-31 10308104 core:AfterOneYear 2026-08-31 10308104 2024-09-01 10308104 bus:Director1 2025-09-01 2026-08-31 10308104 bus:Director1 2026-08-31 10308104 bus:Director1 2024-09-01 2025-08-31 10308104 bus:CompanySecretary1 2025-09-01 2026-08-31 10308104 bus:LeadAgentIfApplicable 2025-09-01 2026-08-31 10308104 2024-09-01 2025-08-31 10308104 2025-08-31 10308104 core:WithinOneYear 2025-08-31 10308104 core:AfterOneYear 2025-08-31 10308104 bus:EntityAccountantsOrAuditors 2024-09-01 2025-08-31 10308104 core:CostValuation core:Non-currentFinancialInstruments 2026-08-31 10308104 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 10308104 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-08-31 10308104 core:Non-currentFinancialInstruments 2026-08-31 10308104 core:Non-currentFinancialInstruments 2025-08-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10308104
England and Wales

 

 

 


Unaudited Financial Statements

for the year ended 31 August 2026

for

THELNET CLINICAL SCIENCE LTD

 
 
2026
£
    2025
£
 
Current assets 18,526  19,530 
Creditors: amount falling due within one year (3,446) (3,446)
Net current assets/(liabilities) 15,080  16,084 
Total assets less current liabilities 15,080  16,084 
Accruals and deferred income 0  (42)
Net assets/(liabilities) 15,080  16,042 
 
Capital and reserves 15,080  16,042 
 



Notes to the Accounts
Statutory Information
Thelnet Clinical Science Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 10308104, registration address Apollo House, Hallam Way, Whitehills Business Park, Blackpool, FY4 5FS, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2025: 1).
3.

Director Advances Credits Note

At 31 August 2026 ThelNet Clinical Science Ltd owed the director £3446 (31 August 2025: £3446)

Director's Responsibilities:
  1. For the year ended 31 August 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:


---------------------------------------------
Thelma Anne Netherway
Director

Date approved: 17 September 2026
1